{
    "2020-06-23": [
        [
            {
                "time": "2018-06-29",
                "original_text": "胰岛素龙头甘李药业IPO发行获投资者热捧 网上线下认购率达99.58%",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "IPO",
                        "认购率",
                        "胰岛素",
                        "龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "发行价格63.32元/股！甘李药业：6月29日在上证所上市",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "发行价格",
                        "上证所",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "甘李药业(603087.SH)将于6月29日上市",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "上市",
                        "股票代码"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "强敌环伺！甘精胰岛素或独木难支 甘李药业IPO之后前路未卜",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "IPO",
                        "甘精胰岛素",
                        "竞争压力"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "甘李药业：国内胰岛素“佼佼者”终登A股资本市场再添新活力",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "胰岛素",
                        "A股",
                        "资本市场"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "甘李下批文、生物谷过会所释放的信号： 成品药IPO审核口径渐变",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "成品药",
                        "IPO审核",
                        "政策信号"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}